Rivakenko Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 3.50 M
as on 10-12-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.77 M
as on 10-12-2024
About Rivakenko Pharma
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹2.77 M.
Manish Tripathi and Rajni Tiwari serve as directors at the Company.
- CIN/LLPIN
U52110UR2021PTC012880
- Company No.
012880
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rivakenko Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Tripathi  | Director | 03-Sep-2021 | Current |
| Rajni Tiwari | Director | 11-Jul-2024 | Current |
Financial Performance of Rivakenko Pharma.
Enhance accessibility to Rivakenko Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rivakenko Pharma?
Unlock access to Rivakenko Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Matr Cinemaya Entertainment Productions Private LimitedActive 10 monthsManish Tripathi and Rajni Tiwari are mutual person
- Aryamgarh Memorial FoundationActive 1 year 1 month
Manish Tripathi and Rajni Tiwari are mutual person
- Nemesia Builder And Developers Private LimitedActive 4 years 2 months
Rajni Tiwari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Aug 2024 | ₹2.77 M | Open |
How Many Employees Work at Rivakenko Pharma?
Rivakenko Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rivakenko Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rivakenko Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
